ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "L01FF" (9)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
Nivolumab (L01FF01) 1 products WHO-DDD  
     Opdivo subkutan 600 mg/5 ml k.A.Injection solution: Nivolumabum 600mg / 5mlBristol-Myers Squibb SAAG
Pembrolizumab (L01FF02) 3 products WHO-DDD  
L IP  Keytruda subkutan 395
mg/2.4 ml		 3933.274294.1010 %Injection solution: Pembrolizumabum 395mg / 2.4mlMSD Merck Sharp &
Dohme AG		A / SLG
L IP  Keytruda subkutan 790
mg/4.8 ml		 7866.548378.8510 %Injection solution: Pembrolizumabum 790mg / 4.8mlMSD Merck Sharp &
Dohme AG		A / SLG
L IP  Keytruda 100 mg/4 ml23933.274294.1010 %Concentrate for infusion: Pembrolizumabum 100mg / 4mlMSD Merck Sharp &
Dohme AG		A / SLG
Atezolizumab (L01FF05) 1 products WHO-DDD  
L IP  TECENTRIQ subkutan 1875
mg/15ml		 3866.574221.5510 %Injektionslösung zur subkutanen Anwendung: Atezolizumabum 1875mg / 15mlRoche Pharma
(Schweiz) AG		A / SLG
Dostarlimab (L01FF07) 1 products WHO-DDD  
L IP  Jemperli 500 mg/10 ml 4472.744880.8010 %Concentrate for infusion: Dostarlimabum 500mg / 10mlGlaxoSmithKline AGA / SLG
Tislelizumab (L01FF09) 1 products WHO-DDD  
L IP  Tevimbra 100 mg/10 ml 1625.651784.4010 %Concentrate for infusion: Tislelizumabum 100mg / 10mlBeOne Medicines I
GmbH		A / SLG
Retifanlimab (L01FF10) 1 products WHO-DDD  
  IP  ZYNYZ 500 mg/20 ml k.A.Concentrate for infusion: Retifanlimabum 500mg / 20mlIncyte Biosciences
International Sàrl		AG
Serplulimab (L01FF12) 1 products WHO-DDD  
  IP  Hetronifly 100 mg/10 ml k.A.Concentrate for infusion: Serplulimabum 100mg / 10mlAccord Healthcare AGAG
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home